FDA DEVICE FACTS
ElintMAX Respiratory Monitor (ElintMAX Monitor A1)
Amptron Medical, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
ElintMAX is indicated for use by healthcare professionals in healthcare facilities to monitor breathing in spontaneously breathing adult patients who are hemodynamically stable and are not under active procedural or post-anesthesia sedation.
ElintMAX is not indicated for use in intensive care or critical care settings, or during the immediate post-anesthesia recovery period. ElintMAX is a non-invasive monitor that graphically displays changes in lung volume over time and presents estimated values for:
• Tidal Volume
• Respiratory Rate
• Minute Ventilation
• Inspiration-to-Expiration Time Ratio (I:E Ratio)
• Rapid Shallow Breathing Index (RSBI) ElintMAX is not intended for apnea detection. The device is intended to supplement, not replace, clinical judgment or other diagnostic tools. Its outputs are to be used as supportive inputs in conjunction with other clinical assessments to evaluate respiratory status.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。